Brex reports that effective expense receipt tracking can streamline financial processes, reduce errors, and enhance ...

Oncolytics Biotech ( ($ONCY) ) has shared an update. On November 12, 2025, Oncolytics Biotech Inc. released its financial results for the three ...

Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management software platforms and integrated payment processing for the ...

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) reported its Q3 2025 results on November 6, 2025. The quarter marked continued ...

MOUNT LAUREL, N.J., Nov. 17, 2025 (GLOBE NEWSWIRE) -- J & J Snack Foods Corp. (Nasdaq: JJSF) (the "Company”) today reported financial results for the fourth quarter and full year ended September 27, ...

Continued execution on collaborations and exploratory investigator-initiated studies with institutional partners Secured net proceeds of approximately $3.9 million from October 2025 offering ...

Record Net Income of $5.6 Million for the Quarter; Retired All $41 Million of Senior and Seller Debt; Retired All Preferred Shares with Redemption Value of $27 Million; and Increased Shareholder ...

Reports third quarter revenue of $1.0 billion, GAAP net loss of $(0.2) billion and GAAP EPS of $(0.51) Narrows 2025 projected ...

NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ending September 30, 2025 with the Securities and Exchange ...

Company achieved FDA alignment on Phase 3 Oz-V trial for the treatment of 2L+ OPSCC, which will evaluate dual primary endpoints with potential of ...

Clinical development programs for doxorubicin-containing microneedle array (D-MNA) and Teverelix, a next generation GnRH ...

The health agency serving the LGBTQ community posted a $2.1 million operating loss in fiscal 2024, an improvement from the ...